Research transparency strategy Andrew George, NED Juliet Tizzard, Director of Policy HRA Board | 15 May 2019

Strategy group

Vision and scope Vision Patients, the public and professionals can easily access useful information about health and care research studies Scope Although the scope of this strategy extends to all health and care research which involves people, their tissue or their personal data, our initial focus is on clinical trials. These are research studies which test the safety and effectiveness of new patient interventions such as medicines, medical devices, surgical techniques, public health measures and behavioural therapies

Areas for consultation General feedback on the vision, scope and HRA’s mission and commitments Views about: measures to increase clinical trials registration measures to increase feedback to participants measures to increase reporting of results considering track record when considering new studies for approval

Strategy timeline June: start consultation April/May June July August Sept/Oct November Draft strategy developed Open online survey Workshops: researchers and patients Workshops: HRA staff and ethics committees Analyse feedback from consultation HRA Board agrees strategy Ongoing engagement with key stakeholders Early Sept: end consultation

Ongoing engagement Outside of the strategy group, we are talking to: Campaigners Registries Academy of Medical Sciences DHSC NHS R&D community Science and Technology Committee

Communications We’re making plans for how to launch the strategy by: Using the media (including medical) to extend the reach of the consultation Working with partner organisations to extend the reach of the consultation Developing a brand identity for our work

Thank you Follow us on Twitter @HRA_Latest Sign up for our monthly newsletter at www.hra.nhs.uk